Sign In
Buy SDGR
$14.93
-0.0100 (-0.0669%)
At Close: Jun 03, 2026
BofA Downgrades Schrodinger On Slower Drug Discovery Ramp
03:15pm, Thursday, 11'th Nov 2021
Schrodinger Inc (NASDAQ:SDGR) reported downbeat third-quarter results, mainly due to lower-than-expected drug discovery revenues, according to BofA Securities. The Schrodinger Analyst: Michael Ryskin
Schrödinger, Inc.'s (SDGR) CEO Ramy Farid on Q3 2021 Results - Earnings Call Transcript
08:04pm, Wednesday, 10'th Nov 2021
Schrödinger, Inc.'s (SDGR) CEO Ramy Farid on Q3 2021 Results - Earnings Call Transcript
Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates
07:05pm, Wednesday, 10'th Nov 2021
Schrodinger, Inc. (SDGR) delivered earnings and revenue surprises of -25.64% and -9.82%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Schrödinger to Host Conference Call to Discuss Third Quarter 2021 Financial Results
08:30am, Friday, 29'th Oct 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will report third quarter 2021 financial results on November 10, 2021.
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:30am, Monday, 18'th Oct 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today reported Inducement Grants under Nasdaq Listing Rule 5635(c)(4).
This Healthcare Company Is Using AI to Develop Drugs
08:15am, Sunday, 03'rd Oct 2021
Could this technology be the future of the pharmaceutical industry?
Schrodinger: An Investment In Drug Discovery In Addition To Software Sales
11:02pm, Sunday, 19'th Sep 2021
Schrodinger: An Investment In Drug Discovery In Addition To Software Sales
Schrodinger's Distributions: 3 High Yielders Likely To Cut
01:51am, Sunday, 12'th Sep 2021
Today's yield chasing exercises are among the most dangerous we have ever seen. While investors love to hear about the stocks that they should own, we like to focus on highlighting the risk side of th
One Stock to Dominate Biotech
08:44pm, Tuesday, 07'th Sep 2021
The amazing biotech advancements coming this decade… breakthroughs in drug discovery… the unrivaled leader in the space from Luke Lango… how it becomes a 10X winner In early January 2020, the
Schrödinger to Present at Four Investor Conferences in September
08:31am, Friday, 03'rd Sep 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will present at four investor conferences in September.
4 Specialized AI Stocks to Buy for the Boom
01:06pm, Tuesday, 31'st Aug 2021
Companies with focused AI technologies appear to be doing better than firms with AI based on general data. Here are four AI stocks to buy.
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:01am, Wednesday, 18'th Aug 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today reported Inducement Grants under Nasdaq Listing Rule 5635(c)(4).
Schrödinger Stock Is Trading Lower After Reporting Deeper Than Expected Q2 Loss
01:41pm, Thursday, 12'th Aug 2021
Schrödinger Inc (NASDAQ: SDGR) has reported Q2 revenues of $29.78 million, +29% Y/Y, slightly missing the consensus of $29.88 million. Software revenue was $24.1 million, +15%.
Schrödinger, Inc. (SDGR) CEO Ramy Farid on Q2 2021 Results - Earnings Call Transcript
12:15pm, Thursday, 12'th Aug 2021
Schrödinger, Inc. (SDGR) CEO Ramy Farid on Q2 2021 Results - Earnings Call Transcript
Recap: Schrodinger Q2 Earnings
07:21am, Thursday, 12'th Aug 2021
Shares of Schrodinger (NASDAQ:SDGR) decreased 0.7% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 880.00% over the past year to ($0.49), wh
